Stock Information
Stoke Therapeutics Inc (STOK)
Ticker Symbol: STOK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,707.09 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.36
Revenue (TTM): $0.42 M
Dividend Yield: N/A
ROE: -59.36%
Latest News
-
JP Morgan Reinstates Overweight on Stoke Therapeutics, Announces $40 Price Target
Fri, Aug 21, 2026 3:06 PM
Key Financials
Financial data not available